174 related articles for article (PubMed ID: 35866784)
1. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review.
Bancheno WM; Adidam SR; Melaku MA
Medicine (Baltimore); 2022 Jul; 101(29):e29616. PubMed ID: 35866784
[TBL] [Abstract][Full Text] [Related]
2. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
Gao Y; Gong M; Zhang C; Kong X; Ma Y
Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
[TBL] [Abstract][Full Text] [Related]
3. [A case of rectal cancer with immune thrombocytopenic purpura that achieved a complete response to continued chemotherapy with eltrombopag].
Tanaka Y; Kuroda H; Honma K; Wakaki K
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(10):852-857. PubMed ID: 37821375
[TBL] [Abstract][Full Text] [Related]
4. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.
Bayraktar S; Eileen B; Shariatmadar S; Lian E
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444
[TBL] [Abstract][Full Text] [Related]
5. Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment.
Lebowa W; Zdziarska J; Sacha T
Blood Coagul Fibrinolysis; 2023 Jul; 34(5):327-332. PubMed ID: 37395226
[TBL] [Abstract][Full Text] [Related]
6. Primary Hepatic Neuroendocrine Carcinoma with Thrombocytopenia Due to Diffuse Bone Marrow and Splenic Infiltration: An Autopsy Case.
Nakano S; Minaga K; Tani Y; Tonomura K; Hanawa Y; Morimura H; Terashita T; Matsumoto H; Iwagami H; Nakatani Y; Akamatsu T; Uenoyama Y; Maeda C; Ono K; Watanabe T; Yamashita Y
Intern Med; 2022 Nov; 61(22):3361-3368. PubMed ID: 35400708
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Breast Cancer with Extensive Osseous Metastasis Presenting with Symptomatic Immune Thrombocytopenic Purpura and Anemia: A Case Report and Review of the Literature.
Niu J; Goldin T; Markman M; Kundranda MN
Case Rep Oncol; 2015; 8(2):256-63. PubMed ID: 26120311
[TBL] [Abstract][Full Text] [Related]
8. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
11. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D
J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462
[TBL] [Abstract][Full Text] [Related]
13. JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report.
Oda Y; Sato S; Kanbe E; Kamata W; Okada S; Tamai Y
Medicine (Baltimore); 2019 Nov; 98(44):e17766. PubMed ID: 31689837
[TBL] [Abstract][Full Text] [Related]
14. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
15. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine.
Helms JM; Ansteatt KT; Roberts JC; Kamatam S; Foong KS; Labayog JS; Tarantino MD
J Blood Med; 2021; 12():221-224. PubMed ID: 33854395
[TBL] [Abstract][Full Text] [Related]
16. A case of successful treatment with eltrombopag for severe immune-related thrombocytopenia induced by atezolizumab:Case report.
Harada S; Imakura T; Sato S; Nokihara H; Nishioka Y
J Med Invest; 2023; 70(3.4):516-520. PubMed ID: 37940542
[TBL] [Abstract][Full Text] [Related]
17. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
[TBL] [Abstract][Full Text] [Related]
18. [Development of myelofibrosis during eltrombopag treatment in a patient with immune thrombocytopenia].
Horikoshi A; Tsukuda J; Abe R; Fujiwara N; Ito E; Takaku T
Rinsho Ketsueki; 2016 May; 57(5):638-41. PubMed ID: 27263792
[TBL] [Abstract][Full Text] [Related]
19. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.
Nishizawa K; Yamashita T; Ogawa Y; Kobayashi H
CEN Case Rep; 2022 Feb; 11(1):43-49. PubMed ID: 34287815
[TBL] [Abstract][Full Text] [Related]
20. Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP.
Choe MJ; Packer CD
Ann Pharmacother; 2015 Jan; 49(1):140-4. PubMed ID: 25325908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
